CIK 0001671927
- Large accelerated filer
Immunocore Holdings plc
Sign in to watch- Ticker
- IMCR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 12355430281
- Business address
- 90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom, OX14 4RY
- Former names
- Immunocore Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-18 | GOLL JOHN SVP, FINANCE & CAO | Sale | −698 | $32.35 | $23K | 653 |
| 2026-02-17 | GOLL JOHN SVP, FINANCE & CAO | Exercise or conversion | +1,351 | 1,351 | ||
| 2026-02-17 | GOLL JOHN SVP, FINANCE & CAO | Exercise or conversion · Restricted Share Units | −1,351 | 4,054 | ||
| 2026-02-17 | GOLL JOHN SVP, FINANCE & CAO | Grant or award · Restricted Share Units | +7,411 | 7,411 | ||
| 2026-02-17 | GOLL JOHN SVP, FINANCE & CAO | Grant or award · Employee Share Option (Right to Buy) | +21,252 | 21,252 | ||
| 2025-02-17 | GOLL JOHN SVP, FINANCE & CAO | Grant or award · Employee Share Option (Right to Buy) | +14,802 | 14,802 | ||
| 2025-02-17 | GOLL JOHN SVP, FINANCE & CAO | Grant or award · Restricted Share Units | +5,405 | 5,405 | ||
| 2024-02-16 | GOLL JOHN SVP, FINANCE & CAO | Grant or award · Employee Share Option (Right to Buy) | +4,930 | 4,930 |
Page 1 of 1 · 8 trades